106 related articles for article (PubMed ID: 151487)
1. Endotoxin receptor site. II. Specificity of endotoxin receptor of platelets and sensitivity to endotoxin in vivo.
Washida S
Acta Med Okayama; 1978 Jul; 32(3):217-23. PubMed ID: 151487
[TBL] [Abstract][Full Text] [Related]
2. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
Bult H; Herman AG
Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
[TBL] [Abstract][Full Text] [Related]
3. Endotoxin receptor site. I. Binding of endotoxin to platelets.
Washida S
Acta Med Okayama; 1978 Jun; 32(2):159-67. PubMed ID: 150201
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.
Kane MA; May JE; Frank MM
J Clin Invest; 1973 Feb; 52(2):370-6. PubMed ID: 4683877
[TBL] [Abstract][Full Text] [Related]
5. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.
Kälsch T; Elmas E; Nguyen XD; Suvajac N; Klüter H; Borggrefe M; Dempfle CE
Basic Res Cardiol; 2007 Sep; 102(5):460-6. PubMed ID: 17624488
[TBL] [Abstract][Full Text] [Related]
8. Platelet-endotoxin interaction: a review.
Semeraro N; Fumarola D; Telesforo P; Vermylen J
Boll Ist Sieroter Milan; 1976; 55(6):577-86. PubMed ID: 798597
[TBL] [Abstract][Full Text] [Related]
9. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes.
Niemetz J; Marcus AJ
J Clin Invest; 1974 Dec; 54(6):1437-43. PubMed ID: 4612059
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
11. Platelet inhibition of renal cortical fibrinolytic activity in the rabbit.
Bergstein JM
Lab Invest; 1976 Aug; 35(2):171-8. PubMed ID: 785093
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
13. Platelet and fibrinogen production: relative sensitivities to endotoxin.
Alving BM; Evatt BL; Levin J; Bell WR; Ramsey RB; Levin FC
J Lab Clin Med; 1979 Mar; 93(3):437-48. PubMed ID: 429852
[TBL] [Abstract][Full Text] [Related]
14. Effect of endotoxin and radio-detoxified endotoxin on cell membranes in vitro.
Kubasova T; Somosy Z; Bertók L; Köteles GJ
Acta Microbiol Acad Sci Hung; 1982; 29(4):235-43. PubMed ID: 6764332
[TBL] [Abstract][Full Text] [Related]
15. Impaired and exhausted platelets in modified generalized Shwartzman reaction: an analogue of hemolytic uremic syndrome associated with endotoxemia.
Fong JS; King-Hrycaj BD
J Lab Clin Med; 1983 Dec; 102(6):847-57. PubMed ID: 6644155
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological properties of SR 27388, a dual antioxidant and PAF receptor antagonist.
Herbert JM; Fraisse L; Bachy A; Valette G; Savi P; Laplace MC; Lassalle J; Roche B; Lale A; Keane PE
J Lipid Mediat; 1993 Aug; 8(1):31-51. PubMed ID: 8257776
[TBL] [Abstract][Full Text] [Related]
18. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Imanishi N; Murakami-Uchida M; Koike H; Natsume Y; Morooka S
Arzneimittelforschung; 1994 Mar; 44(3):317-22. PubMed ID: 8192697
[TBL] [Abstract][Full Text] [Related]
19. Platelet shape change in whole blood: differential effects of endotoxin.
Nystrom ML; Barradas MA; Jeremy JY; Mikhailidis DP
Thromb Haemost; 1994 May; 71(5):646-50. PubMed ID: 8091394
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics.
Haeffner-Cavaillon N; Chaby R; Cavaillon JM; Szabó L
J Immunol; 1982 May; 128(5):1950-4. PubMed ID: 6278022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
